Total Payments
$4,539
2024 Payments
$1,602
Companies
39
Transactions
177
Medicare Patients
193
Medicare Billing
$6,075
Payment Breakdown by Category
Food & Beverage$4,117 (90.7%)
Education$421.97 (9.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,117 | 172 | 90.7% |
| Education | $421.97 | 5 | 9.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Pharmacyclics LLC, An AbbVie Company | $456.87 | 20 | $0 (2023) |
| Celgene Corporation | $411.43 | 18 | $0 (2024) |
| Seagen Inc. | $400.89 | 13 | $0 (2023) |
| Incyte Corporation | $312.56 | 11 | $0 (2024) |
| Janssen Biotech, Inc. | $288.17 | 8 | $0 (2024) |
| Merck Sharp & Dohme LLC | $194.98 | 9 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $192.50 | 9 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $188.13 | 9 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $182.07 | 8 | $0 (2024) |
| ABBVIE INC. | $171.62 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,602 | 62 | Celgene Corporation ($210.25) |
| 2023 | $1,181 | 43 | Seagen Inc. ($285.68) |
| 2022 | $768.15 | 34 | Pharmacyclics LLC, an AbbVie Company ($162.40) |
| 2021 | $987.65 | 38 | Pharmacyclics LLC, An AbbVie Company ($188.75) |
All Payment Transactions
177 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $41.31 | General |
| 12/17/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $28.35 | General |
| Category: ONCOLOGY | ||||||
| 12/13/2024 | BeiGene USA, Inc. | TEVIMBRA (Drug) | Food and Beverage | In-kind items and services | $32.51 | General |
| Category: Oncology | ||||||
| 12/12/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $28.69 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/03/2024 | TerSera Therapeutics LLC | Zoladex (Drug) | Food and Beverage | In-kind items and services | $25.12 | General |
| Category: Oncology | ||||||
| 12/02/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $20.03 | General |
| Category: Hematology | ||||||
| 11/05/2024 | ARRAY BIOPHARMA INC | LORBRENA (Drug), BRAFTOVI, MEKTOVI | Food and Beverage | In-kind items and services | $26.54 | General |
| Category: ONCOLOGY | ||||||
| 11/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Stivarga (Drug), Vitrakvi | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: Oncology | ||||||
| 10/25/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: ONCOLOGY | ||||||
| 10/18/2024 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug) | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: Oncology | ||||||
| 10/16/2024 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Food and Beverage | In-kind items and services | $47.52 | General |
| Category: ONCOLOGY | ||||||
| 10/11/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $27.33 | General |
| Category: Hematology/Oncology | ||||||
| 10/01/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: Hematology | ||||||
| 09/19/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $43.47 | General |
| 09/13/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA, BALVERSA | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Oncology | ||||||
| 09/11/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: ONCOLOGY | ||||||
| 08/23/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: ONCOLOGY | ||||||
| 08/22/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: HORMONE THERAPY | ||||||
| 08/13/2024 | GENZYME CORPORATION | ENJAYMO (Biological) | Food and Beverage | In-kind items and services | $33.00 | General |
| Category: Hematology | ||||||
| 08/06/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Oncology | ||||||
| 08/01/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $26.77 | General |
| Category: Oncology | ||||||
| 07/30/2024 | Incyte Corporation | — | Education | Cash or cash equivalent | $99.00 | General |
| 07/29/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Oncology | ||||||
| 07/26/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, TALVEY | Food and Beverage | In-kind items and services | $29.48 | General |
| Category: Oncology | ||||||
| 07/25/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 193 | 216 | $26,172 | $6,075 |
Total Patients
193
Total Services
216
Medicare Billing
$6,075
Procedure Codes
6
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 34 | 36 | $14,040 | $3,098 | 22.1% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 17 | 18 | $7,578 | $1,618 | 21.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 61 | 67 | $603.00 | $562.80 | 93.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 58 | 63 | $1,827 | $479.43 | 26.2% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 12 | 20 | $1,320 | $211.03 | 16.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 12 | $804.00 | $105.38 | 13.1% |
About Adrienne Wasserman, ARNP
Adrienne Wasserman, ARNP is a Registered Nurse healthcare provider based in Olympia, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/12/2010. The National Provider Identifier (NPI) number assigned to this provider is 1386945905.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Adrienne Wasserman, ARNP has received a total of $4,539 in payments from pharmaceutical and medical device companies, with $1,602 received in 2024. These payments were reported across 177 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($4,117).
As a Medicare-enrolled provider, Wasserman has provided services to 193 Medicare beneficiaries, totaling 216 services with total Medicare billing of $6,075. Data is available for 1 year (2023–2023), covering 6 distinct procedure/service records.
Ad
Practice Information
- Specialty Registered Nurse
- Other Specialties Adult Health, Nurse Practitioner
- Location Olympia, WA
- Active Since 11/12/2010
- Last Updated 04/23/2024
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1386945905
Products in Payments
- IMBRUVICA (Drug) $493.92
- REBLOZYL (Biological) $251.31
- KEYTRUDA (Biological) $194.98
- OPDIVO (Biological) $192.50
- ERLEADA (Drug) $133.50
- TAZVERIK (Drug) $129.79
- EPKINLY (Drug) $126.86
- JAKAFI (Drug) $116.41
- Stivarga (Drug) $106.12
- BLENREP (Biological) $102.32
- ENJAYMO (Biological) $97.68
- Pomalyst (Drug) $95.68
- ADCETRIS (Biological) $93.78
- KISQALI (Drug) $89.95
- CALQUENCE (Drug) $87.49
- Zoladex (Drug) $79.48
- MONJUVI (Drug) $77.32
- PADCEV (Biological) $68.14
- Empaveli (Drug) $60.60
- INLYTA (Drug) $58.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Olympia
Lisa Krapp
Registered Nurse — Payments: $3,393
Registered Nurse $3,393
Montana Blackley, Crna, CRNA
Registered Nurse — Payments: $3,152
Registered Nurse $3,152
Maria Socorro Gandara, Fnp, FNP
Registered Nurse — Payments: $1,339
Registered Nurse $1,339
Rebecca Taylor
Registered Nurse — Payments: $1,033
Registered Nurse $1,033
Quesha Foster, Aprn, APRN
Registered Nurse — Payments: $981.15
Registered Nurse $981.15
Peter Hausman, Arnp, Pmhnp-Bc, ARNP, PMHNP-BC
Registered Nurse — Payments: $671.12
Registered Nurse $671.12